Streetbeat News

Stock Prices

PFE

Investors have taken a predominantly bearish stance on Pfizer (NYSE:PFE) as observed through recent options trading activity. Benzinga's options scanner detected 10 significant trades, with 90% of the sentiment being bearish. The trades suggest a targeted price range of $20.0 to $30.0 for Pfizer over the next few months. Analysts have mixed ratings, with price targets ranging from $29 to $36.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 6:31 pm

CAT

Caterpillar (NYSE:CAT) has outperformed the market over the past 10 years with an average annual return of 12.57%, surpassing the market by 2.07% annually. A $1000 investment in CAT 10 years ago would be worth $3,262.32 today.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 6:30 pm

ATI

ATI (NYSE:ATI) has significantly outperformed the market over the past 5 years, delivering an average annual return of 20.82%. A $1000 investment in ATI 5 years ago would be worth $2,768.67 today. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 6:30 pm

QCOM

Qualcomm's CFO announced a new focus on on-device AI, marking a significant shift from their traditional wireless technology. The company introduced the Snapdragon X elite platform for PCs and highlighted the role of AI in the automotive industry.

Portfolio Pulse from Abbey Higginbotham

May 30, 2024 | 6:29 pm

SPY

Federal Reserve's John Williams stated that the central bank has time to assess incoming data before making any policy changes. He emphasized that the market understands the Fed's outlook shifts with new data and mentioned that the neutral rate of interest remains uncertain.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 6:27 pm

CRM

NVDA

Jim Cramer attributes the recent 20% drop in Salesforce (CRM) stock to the rapid advancement of AI, particularly driven by Nvidia (NVDA). Salesforce reported its first revenue miss in over a decade and issued weak guidance for the next quarter. Cramer suggests that companies are reassessing their software spending due to the potential for AI to reduce the need for human labor.

Portfolio Pulse from Adam Eckert

May 30, 2024 | 6:26 pm

PARA

Paramount shares are trading higher following a report suggesting the company's independent committee will review Skydance's enhanced offer soon.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 6:25 pm

DELL

MSFT

Dell Technologies Inc (NYSE:DELL) shares are trading lower on Thursday, pulling back from recent gains driven by strong demand for AI servers and PCs. The stock has surged over 120% year-to-date, bolstered by positive analyst updates and price target revisions. However, broader tech sector weakness, influenced by Salesforce's revenue miss, is impacting Dell. Dell is set to release its fiscal first-quarter financial results, with high expectations for earnings and revenue.

Portfolio Pulse from Adam Eckert

May 30, 2024 | 6:24 pm

CNPOF

CNTMF

SMG

Cansortium Inc. (OTC:CNTMF) and RIV Capital Inc. (OTC:CNPOF) announced a merger to operate in Florida, New York, Texas, and Pennsylvania, covering 25% of the U.S. population. Supported by ScottsMiracle-Gro (NYSE:SMG), the merger will eliminate $175 million in debt and is expected to generate $5-10 million in annual cost synergies. The combined company will have a pro forma cash balance of $74 million as of March 31, 2024, and will operate under the Cansortium name.

Portfolio Pulse from Nicolás Jose Rodriguez

May 30, 2024 | 6:21 pm

JNJ

SRPT

SWAV

Sarepta Therapeutics (NASDAQ:SRPT) stock is rising after the announcement that it will be added to the S&P MidCap 400, replacing Shockwave Medical (NASDAQ:SWAV). Johnson & Johnson (NYSE:JNJ) is expected to acquire Shockwave Medical, pending final closing conditions.

Portfolio Pulse from Dylan Berman

May 30, 2024 | 6:20 pm